Fortis Healthcare Ltd

Net profit of Fortis Healthcare rose 82.43% to Rs 321.92 crore in the quarter ended September 2025 as against Rs 176.46 crore during the previous quarter ended September 2024. Sales rose 17.25% to Rs 2331.44 crore in the quarter ended September 2025 as against Rs 1988.39 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales2331.441988.39 17 OPM %23.8621.87 - PBDT507.71415.87 22 PBT401.87320.82 25 NP321.92176.46 82 Powered by Capital Market - Live

Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live

Fortis had been previously managing the facility under an operations & management (O&M) arrangement since its launch in October 2022 and will continue to operate the facility as Fortis Hospital Greater Noida under the new lease arrangement. With the above, Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network. The hospital is built on a 1.35-acre UPSIDA-leased land parcel with 2.7 lakh square feet of built-up area. The facility has the potential to expand capacity by an additional 50 beds within the existing set-up; taking the total to 250 beds. Strategically located, it is well connected by the Greater Noida Expressway, Metro (Aqua line), Yamuna Expressway, and Eastern Peripheral Expressway, and is 34 km from the upcoming Jewar International Airport. Dr. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, said: The addition of Fortis Hospital Greater Noida underlines our commitment to strengthening healthcare delivery across NCR. Greater Noida is emerging as an important hub, driven by urbanisation, industrial growth, and rising patient demand. With this expansion, we are not only enhancing access to advanced tertiary care but also reinforcing Fortis' leadership in the region. Fortis Healthcare is a leading integrated healthcare delivery service provider in India. Its verticals include hospitals, diagnostics, and day care specialty facilities. Currently, the company operates 33 healthcare facilities (including JVs and O&M facilities) across 11 states. The company's network comprises over 5,700 operational beds (including O&M beds) and 400 diagnostics labs. The company reported a 56.83% surge in consolidated net profit to Rs 260.28 crore in Q1 FY26, compared to Rs 165.96 crore in Q1 FY25. Revenue from operations rose 16.55% year-on-year (YoY) to Rs 2,166.72 crore in the quarter ended 30 June 2025. The scrip rose 0.36% to currently trade at Rs 928.15 on the BSE. Powered by Capital Market - Live

Fortis Healthcare  announced that its wholly owned subsidiary, International Hospital (IHL), has entered into a 15-year lease agreement with RR Lifesciences for a ~200-bed fully operational multi-specialty hospital in Greater Noida. Fortis had been previously managing the facility under an Operations & Management (O&M) arrangement since its launch in October 2022 and will continue to operate the facility as Fortis Hospital Greater Noida under the new lease arrangement. With the above, Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network. The hospital is built on a 1.35-acre UPSIDA-leased land parcel with 2.7 lakh sq. ft. of built-up area. The facility has the potential to expand capacity by an additional 50 beds within the existing set-up; taking the total to ~250 beds. Strategically located, it is well connected by the Greater Noida Expressway, Metro (Aqua line), Yamuna Expressway, and Eastern Peripheral Expressway, and is 34 km from the upcoming Jewar International Airport. Commenting on the development, Dr. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, said: 'The addition of Fortis Hospital Greater Noida underlines our commitment to strengthening healthcare delivery across NCR. Greater Noida is emerging as an important hub, driven by urbanisation, industrial growth, and rising patient demand. With this expansion, we are not only enhancing access to advanced tertiary care but also reinforcing Fortis' leadership in the region. Our focus will remain on delivering high-quality, ethical, and patient-centric care while exploring opportunities for further growth.'Powered by Capital Market - Live

The upcoming hospital will be constructed by the Ekana Group near Gomti Nagar in the state capital of Uttar Pradesh. Under the agreement, Fortis Healthcare will oversee operations and management once the facility is ready. The planned hospital is expected to function as a Centre of Excellence for tertiary care services, offering advanced medical infrastructure and global best practices to patients in Lucknow and beyond. Dr Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare said, We are delighted to partner with Ekana Group to bring a state-of-the-art tertiary healthcare facility to the heart of Lucknow. Once operational, this new 550-bed super-specialty hospital near Gomti Nagar will significantly enhance access to advanced medical care for the city and its surrounding regions. This collaboration marks Fortis Healthcare's third major presence in Uttar Pradesh, joining our network hospitals in Noida and Greater Noida, and underscores our steadfast commitment to expanding high-quality healthcare across the state.' Uday Sinha, Promoter of Ekana Group, said, 'We are happy to join hands with one of the leading healthcare chains in India - Fortis Healthcare to develop a leading-edge tertiary care hospital, one that will significantly enhance access to advanced medical services and deliver patient care where it's most needed.' Fortis Healthcare is a leading integrated healthcare delivery service provider in India. Its verticals include hospitals, diagnostics, and day care specialty facilities. As of now, the company operates 33 healthcare facilities (including JVs and O&M facilities) across 11 states, with a network of over 5,700 operational beds and 400 diagnostics labs. The company reported a 56.83% surge in consolidated net profit to Rs 260.28 crore in Q1 FY26, compared to Rs 165.96 crore in Q1 FY25. Revenue from operations rose 16.55% year-on-year (YoY) to Rs 2,166.72 crore in the quarter ended 30 June 2025. Shares of Fortis Healthcare shed 1.03% to Rs 953.65 on the BSEPowered by Capital Market - Live

Revenue from operations rose 16.55% year-on-year (YoY) to Rs 2,166.72 crore in the quarter ended 30 June 2025. Profit before exceptional items and tax stood at Rs 337.94 crore in Q1 FY26, up 47.02% from Rs 229.85 crore in the same quarter last year. The company also reported exceptional gains of Rs 12.63 crore in Q1 FY26. Operating EBITDA stood at Rs 491 crore, reflecting a 43.2% growth compared to Rs 343 crore in Q1 FY25. Operating EBITDA margin improved to 22.6% from 18.4% in the year-ago quarter. In Q1 FY26, revenue from the hospital business grew 18.6% to Rs 1,838 crore, up from Rs 1,549 crore in Q1 FY25. This growth was driven by a higher ARPOB (Average Revenue Per Occupied Bed) and a 7.8% increase in occupied beds compared to the previous year. The occupancy rate for the hospital business stood at 69% in Q1 FY26, up from 67% in Q1 FY25. ARPOB rose 9.95% to Rs 2.65 crore per annum, compared to Rs 2.41 crore per annum last year. The Average Length of Stay (ALOS) declined to 4.09 days from 4.16 days. International Patient revenues grew 17% to Rs 132 crore in Q3 FY25 as against Rs 113 crore in Q3 FY24. The business contributed 7.7% to overall hospital business revenues, similar the corresponding previous period. International patient revenues grew 21% to Rs 154 crore in Q1 FY26, up from Rs 127 crore in Q1 FY25. The segment contributed 7.9% to the hospital business revenues, slightly up from 7.8% in Q1 FY25. Key surgical procedures showed strong growth: Robotic surgeries rose 75%, radiation therapy increased 53%, and orthopedic procedures grew 22% year-on-year. Digital channels, including the website, mobile app, and digital campaigns, saw a 16.8% YoY increase in revenue contribution. These channels accounted for 29.5% of overall hospital revenues, compared to 29.9% in Q1 FY25. The diagnostic business gross revenue rose 7.4% to Rs 368.8 crore in Q1 FY26 from Rs 343.5 crore in Q1 FY25. Operating EBITDA margin, based on gross revenues, stood at 23.0%, up from 16.1% in the previous year. Excluding one-offs, the margin was 18.7% in Q1 FY25. During the quarter, Agilus Diagnostics conducted approximately 10.13 million tests, up from 9.57 million tests in Q1 FY25. In July 2025, Fortis signed an Operations and Maintenance Services (O&M) agreement with Gleneagles India. Under the agreement, Fortis will manage around 700 beds across five hospitals and one clinic in the Gleneagles network. As of 30 June 2025, the company's net debt stood at Rs 1,869 crore, with a Net Debt to EBITDA ratio of 0.92x, compared to 0.22x as of 30 June 2024 (based on Q1 annualized EBITDA). Net Debt to Equity rose to 0.20x from 0.04x in the prior year. Dr Ashutosh Raghuvanshi, MD and CEO, Fortis Healthcare stated, 'We have witnessed a healthy start to the financial year, as demonstrated in our Q1 earnings for both hospital and diagnostic businesses. The recently executed O&M services agreement with Gleneagles India expands our geographic footprint and provides an opportunity to leverage our combined strengths to optimize operations and enhance efficiencies. The company also consummated the acquisition of Shrimann Superspecialty Hospital in Jalandhar, further strengthening our presence in Punjab region with approx. 1,000 beds.' He further added 'In the diagnostics business, we have witnessed a strong recovery in both revenues and EBITDA margins which is reflective of the brand building initiatives undertaken over the last few quarters. We expect this growth momentum to continue going forward.' Fortis Healthcare is a leading integrated healthcare delivery service provider in India. Its verticals include hospitals, diagnostics, and day care specialty facilities. As of now, the company operates 33 healthcare facilities (including JVs and O&M facilities) across 11 states, with a network of over 5,700 operational beds and 400 diagnostics labs. The scrip hit 52 week high at Rs 904.75 in intraday today. Powered by Capital Market - Live

Net profit of Fortis Healthcare rose 56.83% to Rs 260.28 crore in the quarter ended June 2025 as against Rs 165.96 crore during the previous quarter ended June 2024. Sales rose 16.56% to Rs 2166.72 crore in the quarter ended June 2025 as against Rs 1858.90 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales2166.721858.90 17 OPM %22.6518.43 - PBDT439.42320.85 37 PBT337.94229.85 47 NP260.28165.96 57 Powered by Capital Market - Live

Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 6 August 2025.Powered by Capital Market - Live

Fortis Healthcare announced that the 29th Annual General Meeting(AGM) of the company will be held on 11 August 2025.Powered by Capital Market - Live

Net profit of Fortis Healthcare rose 2.89% to Rs 183.89 crore in the quarter ended March 2025 as against Rs 178.73 crore during the previous quarter ended March 2024. Sales rose 12.39% to Rs 2007.20 crore in the quarter ended March 2025 as against Rs 1785.88 crore during the previous quarter ended March 2024. For the full year,net profit rose 29.28% to Rs 774.21 crore in the year ended March 2025 as against Rs 598.88 crore during the previous year ended March 2024. Sales rose 12.91% to Rs 7782.75 crore in the year ended March 2025 as against Rs 6892.92 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales2007.201785.88 12 7782.756892.92 13 OPM %21.7021.34 -20.4018.39 - PBDT392.35360.47 9 1481.991184.45 25 PBT290.12268.24 8 1096.38841.95 30 NP183.89178.73 3 774.21598.88 29 Powered by Capital Market - Live